Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine for Cognitive Dysfunction in MS
NCT01615887Phase 2Completed
- Sponsor
- University at Buffalo
- Start
- Nov 2009
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisdexamfetamine in multiple sclerosis (MS), sponsored by University at Buffalo. Started Nov 2009; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01615887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01615887.